FDA Roundup: May 20, 2022
FDA Roundup: May 20, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-20-2022
FDA Roundup: May 20, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-20-2022
FDA Urges Drug Manufacturers to Develop Risk Management Plans to Promote a Stronger, Resilient Drug Supply Chain
http://www.fda.gov/news-events/press-announcements/fda-urges-drug-manufacturers-develop-risk-management-plans-promote-stronger-resilient-drug-supply
New FDA Draft Guidance Aims to Increase Safety Information About Dietary Supplement Marketplace
http://www.fda.gov/news-events/press-announcements/new-fda-draft-guidance-aims-increase-safety-information-about-dietary-supplement-marketplace
Regulación internacional sobre la edad para el uso de la segunda dosis de refuerzo de la vacuna contra el SARS-CoV-2
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1369299
FDA Roundup: May 17, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-17-2022
Nirmatrelvir/ritonavir para pacientes infectados por SARS-CoV-2 não hospitalizados e de alto risco
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1368825